We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Imagen is a company that has developed an automated, sophisticated algorithmic technique, PredictRx, to find the right treatment for any cancer type. Imagen collects the cancer samples from a patient, grows it in its specialised growth medium, and then subjects the medium to an automated fluorescence microscopy screening to measure drug responses on live tumour cells. The company's AI-powered biobank of over 150,000 drug responses then gives the best possible cancer treatment options, allowing the company to expand in the pharmaceutical sector by satisfying its unmet demand for patient-derived cancer models. Imgen requires investment to scale its infrastructure to create the world's leading 'Biobank' of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,036,436
Service Robotics Ltd is a unique service designed to help older adults live independently in their own homes. This game-changing service offers voice-enabled face-to-face human support through an adorable intelligent Genie robot. The company's roadmap includes IT integration to turn the home into a cocoon of wellness, health, and companionship. The company has been actively piloting the GenieConnect® platform solution since 2018. Service Robotics Ltd won its first contract in November 2019 from the NHS/SBRI programme. GenieConnect® has agreed on pilot projects with 3 care and retirement organisations, applied for an Innovate UK grant in March.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £569,430
SleepCogni combines a handheld device and a Software as a Service (SaaS) platform to help users wind down by collecting physiological, behavioural and environmental data. The company points out that 1 million people in the UK take sleeping pills for insomnia. SleepCogni intends to change this with its product. It claims that its device receives data from fifteen different sensors, providing detailed insights into a user’s sleep struggle to further assist in clinical intervention, including procedures such as CBT-I (Cognitive Behavioural Therapy for Insomnia). The company's initial target sleep clinics are the UK and the US, with the US sleep clinic market estimated to be worth $9 billion in 2020. SleepCogni has eleven granted and four pending patents in various territories, a trademark on the logo and protection of specific handheld trigger hardware. They state they will use the investment received to commercialise their product.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £577,270
Coinrule is a smart assistant designed for millennials looking to automate their investments in cryptocurrencies, financial assets and build trading strategies without having to program a single line of code. The platform empowers regular traders and investors to compete with professional algorithmic traders and hedge funds. Users can pick 'building blocks' via a simple interface to create trading strategies which also get backtested on historical data. The company aims to make trading an accessible option for all. They have received awards such as MKB Fintech Lab - Cohort 2018, Pioneer 500, and Alpha Startup at Web Summit 2018. Their exit strategy would be a sale to a larger player either in the crypto space (i.e. Binance/Coinbase) or in the traditional brokerage space (i.e. IG Index, Fidelity).

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £160,000
Debtech is a legal intelligence platform that aims to become a global automation portal for every type of finance agreement - from simple mortgages to billion-dollar corporate loans. Debtech has a two-tiered format for its business. Its Tier 1 'Platform' connects finance stakeholders - from lenders and lawyers to CFOs and borrowers - on one single platform so that everyone is in one place for the lifecycle of the agreement. Its Tier 2 'Marketplace' is an 'App Store' of simple, plug-and-play apps where one app automates one manual workflow. The company asserts that the global legal intelligence market would touch £29.5 billion by value in 2026. Debtech cites that its portal allows finance organisations to achieve time savings of over 90% and cost savings of up to 50x compared to conventional offline platforms. The company seeks to raise £150,000 (SEIS) of equity funding to upgrade the platform's infrastructure for Most Valuable Product (MVP) Version 1 within 90-days to create MVP V2, onboard its six early corporate customers for paid trials on MVP v2, and build five core apps.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £159,512
Lifetise is a financial planning platform that enables prospective clients to plan significant expenditures such as buying a home, marital expenses, child-rearing and retirement. Presently, they have come up with two major offerings: Homefinder and Childminder. The first one acts as a tool that shows money required to afford a home in the UK and the amount of time taken to save the money while the latter helps parents to calculate the costs of childcare along with their work. Lifetise is targeting the 25-40 age group in the UK whose population numbers are approximately 14 million. To date, they have been featured in prominent publications like Evening Standard and Stylist with an active following on Reddit. The company has secured 12,000 customers after their partnering with Accenture's Fintech Accelerator Programme. With the investment, Lifetise will spend more on developing its applications with a focus on all major life expenditures, marketing on social media channels, build partnerships and human resources.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £254,240
Upside is a financial technology entity that allows its users to earn cashbacks on current purchases so that they can save on their next purchase. The app uses an open-banking-marketing-platform that enables customers to automatically start saving by harvesting upside from their everyday spending and allows retailers to sell more inventory. Upside claims that 11.5 million people in the UK have less than £100 in savings. It aims to solve this problem and become a contender in the cashback segment. Since its incorporation in January 2020, Upside has raised £540,000+ from founders and SEIS Angel Investors. It has also signed-up 700+ consumers as private alpha testers to smoothen the app. The company will use the investment to onboard more retail partners, build out a self-serve retailer platform, build out Upside-as-a-Service Application Programming Interface (API) gateway, and prepare for Seed funding in Q1 of 2021.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £351,047
YoungPlanet enables parents to put their children's unused things to use with new families and away from landfills for free via its app. The company cites PwC data estimating the UK’s sharing economy to be worth £9 billion by 2025. It aims to be a contender in this segment. The company argues further that 10-year-olds in the UK will own on average 238 toys at any one time and yet play with just 12. This leads to UK households wasting over 25 million tonnes a year, with one-fourth of this number ending up in landfills as per the Department for Environment, Food and Rural Affairs (DEFRA). YoungPlanet aims to change this. It has onboarded 36,000 users on its platform to date and featured in press publications such as BBC News, Vanessa Feltz, and LadBible. YoungPlanet will use the investment to scale nationally, begin generating first phase revenue via brand sponsorship of events, branded gamification, and Business-to-Business (B2B) subscriptions for semi-closed communities via its app.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £547,103
Equipsme is a company that aims to democratise health insurance by making it affordable for businesses. The company offers flexible fixed-price packages to employees while giving them the option to upgrade their package to avail more features upon payment. Members can speak to a general physician round the clock, have physiotherapy sessions, avail regular health checks and, if necessary, be quickly referred to a consultant for diagnosis and treatment. Members can access these features through a simple-to-use application. Since February 2018, the company has secured an exclusive 5-year insurance capacity deal with AXA PPP Healthcare and grown its members by 130.5% Year-on-Year (YoY) (to May 2020) with a 95% broker renewal retention rate. The company will use the investment to enhance its user experience and scale its marketing as it announces its partnerships with organisations such as Starling Bank and Simply Business.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £879,204
Span Health is a digital care platform that aims to help people avoid lifestyle-induced diseases, symptoms, medication, and complications. The company has helped more than 10,000 people to live a better and longer life. Span Health's easy-to-use mobile application allows patients to chat with clinicians, order blood tests at home, book video consultations, and see results in the application itself. Moreover, in 2019, the company agreed on a National Health Service (NHS) pilot test for 100 patients in collaboration with the National Institute of Health Research in North West London. Span Health will use the investment to provide employees with blood tests to screen for health risk factors and recover from detected illness safely and sustainably, improve its platform data insights, prediction and machine learning to better structure the clinician's processes, and further reduce its operational costs.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £134,892
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph